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The role of non-muscle myosin IIA (heavy chain encoded by the non-muscle myosin
heavy chain 9 gene, Myh9) in immunological synapse formation is controversial. We have
addressed the role of myosin IIA heavy chain protein (MYH9) in mouseT cells responding to
MHC-peptide complexes and ICAM-1 in supported planar bilayers – a model for immunolog-
ical synapse maturation. We found that reduction of MYH9 expression levels using Myh9
siRNA in proliferating mouse CD4+ AND T cell receptor (TCR) transgenic T cells resulted
in increased spreading area, failure to assemble the central and peripheral supramole-
cular activation clusters (cSMAC and pSMAC), and increased motility. Surprisingly, TCR
microcluster speed was reduced marginally, however TCR microclusters dissipated prior
to forming a cSMAC.TCR microclusters formed in the Myh9 siRNA-treatedT cells showed
reduced phosphorylation of the Src family kinase (SFK) activation loop and displayed
reduced cytoplasmic calcium ion (Ca2+) elevation. In addition, Myh9 siRNA-treated cells
displayed reduced phosphorylation of the Cas-L substrate domain – a force-dependent
SFK substrate – which was observed in control siRNA-treated cells in foci throughout
the immunological synapse except the cSMAC. Cas-L exhibited TCR ligation-dependent
induction of phosphorylation. These results provide further evidence that T cell activation
is modulated by intrinsic force-generating systems and can be viewed as a mechanically
responsive process influenced by MYH9.
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INTRODUCTION
T cells are highly migratory cells that cycle through the blood,
lymph, and peripheral lymphoid organs, scanning antigen pre-
senting cells (APCs) in search of their cognate antigen (Miller
et al., 2004). T cells demonstrate both remarkable fidelity and
sensitivity such that they are able to recognize as few as 10 acti-
vating peptide-MHC (pMHC) complexes among approximately
a million self-pMHC on the surface of an APC (Irvine et al.,
2002). Recognition of activating pMHC complexes results in acute
T cell arrest and stable signal integration via formation of an
immunological synapse (Dustin et al., 1998; Monks et al., 1998;
Grakoui et al., 1999). Signal transduction through the stable, inte-
grin dependent immunological synapses is critical for generation
of immunological memory (Scholer et al., 2008). T cells initiate
signaling within seconds of contacting an APC, but the immuno-
logical synapse undergoes a maturation process over a period of
a few minutes to form three supramolecular activation clusters
(SMACs; Monks et al., 1998; Freiberg et al., 2002). The first to
form is the distal SMAC (dSMAC), which emerges as an actin-
rich ring of close contact as the T cell spreads on the antigen
positive surface (Grakoui et al., 1999; Dustin and Cooper, 2000;
Bunnell et al., 2001). Segregated T cell receptor (TCR) and leuko-
cyte function-associated antigen-1 (LFA-1) microclusters form as
the F-actin ring expands to initiate TCR signaling (Grakoui et al.,
1999; Krummel et al., 2000; Bunnell et al., 2002; Campi et al., 2005;
Yokosuka et al., 2005; Kaizuka et al., 2007). Once the dSMAC is
fully extended, distal microclusters undergo centripetal transport
to assemble the peripheral SMAC (pSMAC) through which larger
TCR microclusters with robust signaling percolate toward the cen-
ter (Yokosuka et al., 2005; Varma et al., 2006). In the last stage of
synapse maturation the large TCR microclusters reach the center
and undergo a transformation from individual microclusters into
a stable central SMAC (cSMAC) that lacks active signaling in a
mechanism dependent upon the endosomal complexes required
for transport (ESCRT) component TSG101 (Varma et al., 2006;
Vardhana et al., 2010). A mature synapse has all three elements,
the dSMAC, pSMAC, and cSMAC. In a multifocal synapse formed
between T cells and dendritic cells there are multiple cSMAC like
structures (Tseng et al., 2008). The role of cytoskeletal transport in
this process is well established (Mossman et al., 2005; Varma et al.,
2006; DeMond et al., 2008; Hashimoto-Tane et al., 2011), but the
role of the actin based motor myosin IIA (MYH9, encoded by the
gene Myh9) has been controversial.
F-actin plays a critical role in TCR signaling and immuno-
logical synapse maturation (Valitutti et al., 1995; Varma et al.,
2006). The role of MYH9 has been less clear. In pMHC specific
mouse effector T cells, MYH9 is the only myosin II expressed.
Initial efforts to understand the role of this myosin applied Myh9
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siRNA and inhibitors like blebbistatin. These studies suggested
that MHY9 is not required for immunological synapse formation
in a cell–cell system, but did not enable more detailed analysis
of how these junctions formed (Jacobelli et al., 2004). In con-
trast, a recent study using blebbistatin with primary mouse T
cells interacting with supported planar bilayers containing specific
pMHC and ICAM-1 demonstrated several defects in immunolog-
ical synapse formation including slowing of early actin flow and
TCR microcluster translocation (Yu et al., 2012). This is consis-
tent with earlier observations of dSMAC contractile oscillations,
which are a signature of periodic non-muscle myosin II activation
in lamellipodia (Dobereiner et al., 2006; Sims et al., 2007). This
force-sensing signature suggested that there might be a mechani-
cal component to TCR signaling (Sims et al., 2007). Studies with
primary human T cells and the Jurkat T cell line demonstrated a
profound effect of MYH9 inhibition by blebbistatin or silencing
by Myh9 siRNA on signaling and immune synapse maturation
(Ilani et al., 2009; Babich et al., 2012; Yi et al., 2012). Specifi-
cally, superantigen induced activation of Jurkat T cell line by the
Raji B cell line was inhibited by blebbistatin as was the interac-
tion of the cells. Analysis of immunological synapse dynamics
using ICAM-1 and anti-CD3 presented in a mobile form on pla-
nar bilayers revealed slowing or stasis of TCR microclusters and
defective signaling following blebbistatin or Myh9 siRNA treat-
ment. The centripetal actin flow was only completely abrogated
when both actin polymerization and myosin II based contractility
were blocked (Yi et al., 2012). Similar results have been obtained
in a system where anti-CD3 is adsorbed to glass substrates, leading
to early activation of centripetal F-actin flow (Babich et al., 2012).
Specific defects in TCR signaling have been variably observed, but
there is a consensus that Ca2+ signaling is attenuated when MYH9
activity is blocked (Ilani et al., 2009; Babich et al., 2012; Yi et al.,
2012; Yu et al., 2012).
The role of MYH9 in the maturation and stability of LFA-
1/ICAM-1 interactions within the pSMAC is less studied, although
a critical role for non-muscle myosin II in the maturation of
nascent integrin-rich adhesions in other cell types has been con-
clusively demonstrated (Choi et al., 2008). MYH9 associates with
LFA-1 upon ligation and is involved in the turnover of LFA-
1–ICAM-1 interactions during migration in vitro (Morin et al.,
2008). MYH9 immunoreactivity is highly enriched in the pSMAC
and blebbistatin treatment results in defects in pSMAC formation
(Yi et al., 2012; Yu et al., 2012). Overall, immunological synapse
stability has not been examined.
Mechanotransdution is the process by which physical forces,
such as the pushing force of actin polymerization and pulling
forces of non-muscle myosin II against F-actin attached to adhe-
sion sites, is converted into a chemical signal (Vogel and Sheetz,
2006). One of the best-characterized force sensors in non-muscle
cells is the family of proteins containing a Crk associated sub-
strate (Cas) substrate domain. In stromal cells, p130Cas has been
shown to undergo phosphorylation by SFK Fyn in response to
stretching of the purified protein or the protein within a live cell
(Sawada et al., 2006). Phosphorylation of the Cas substrate domain
in p130 Cas generates a binding site for Crk, which binds the Rap1
exchange factor C3G. Since this process takes place in the con-
text of adhesion formation, the generation of Rap1 could be seen
as a feed-forward process. The hematopoietic family member of
the CAS family is Cas-L (gene Nedd9), which has an established
role in T cell trafficking, but not activation (Regelmann et al.,
2006). Treatment of T cells with the myosin II inhibitor blebbis-
tatin or the myosin light chain kinase inhibitor ML-7 both reduce
Cas-L phosphorylation in the immunological synapse (Yu et al.,
2012). However, in these studies it was not determined if Cas-L
phosphorylation was related to TCR signaling or purely to LFA-1
interaction with ICAM-1, which is observed in the absence of spe-
cific pMHC to activate TCR signaling. Cas-L may be of interest
both functionally and as an endogenous force sensor in T cells.
In order to further clarify the role of MYH9 in immunologi-
cal synapse formation with natural pMHC ligands in supported
planar bilayers we have used high-resolution microscopy in combi-
nation with siRNA-mediated suppression of MyH9. Using siRNA
targeting multiple sequences in the Myh9 transcript, we have
determined that MYH9 plays critical roles in the formation of
the pSMAC and the cSMAC. Furthermore, we have found that
Cas-L displays strong MYH9-dependent phosphorylation in foci
throughout the immunological synapse, in response to TCR trig-
gering. These studies support a model in which MYH9 plays
a major role in immunological synapse formation, function in
signaling, and stability.
MATERIALS AND METHODS
REAGENTS
Affinity purified polyclonal antibodies against phospho-Src (Cell
Signaling Technology – cat#6943) and Cas substrate domain (Cell
Signaling Technology – cat#4015) were obtained from Cell Sig-
naling Technology and relevant fluorescently labeled secondary
antibodies were obtained from Jackson Immunoresearch. H57 Fab
were obtained from Biolegend and were labeled with Alexa568. All
fluorescent dyes were purchased from Molecular Probes (Invit-
rogen) or Amersham Biosciences and conjugated with desired
proteins according to manufacturer’s protocol.
CELL CULTURE
Transgenic AND B10Br Mouse splenocytes were expanded in pres-
ence of 1µM moth cytochrome C (MCC 88–103) peptide to
generate AND T cell blasts. These blasts were further expanded in
IL-2 (50 U/ml) containing DMEM culture media. Work with ani-
mals was carried out under the supervision of and with approval
from the NYU School of Medicine Institutional Animal Care and
Use Committee.
siRNA TREATMENT
siRNAs targeted against mouse Myh9 were obtained from Dhar-
macon: Myh9 siRNA#1 J-040013-05; Myh9 siRNA#2 J-040013-06;
Myh9 siRNA#3 J-040013-07. Myh9 siRNA#1 was used unless oth-
erwise indicated and the Myh9 siRNA mix contains all three siR-
NAs (#1, #2, #3). The control non-specific siRNA was also obtained
from Dharmacom: D-001810-10-20. AND T cell blasts were elec-
troporated on day 4 with 2–4µg of RNA duplexes using an Amaxa
Nucleoporator® according to manufacturer’s instructions. The
amount of MYH9 protein was determined by immunoblotting
on three million cells with separation on SDS-PAGE and normal-
ization with β-actin. Proteins were detected with a Licor Odyssey
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scanner. 60–85% reduction of MYH9 levels was achieved with one
round of electroporation (as in Figures 3, 4, and 7), whereas a
90–95% reduction could be achieved with a second round of elec-
troporation on day 6 (as in Figures 1, 2, 5, and 6). AND T cells
were utilized for experiments 2–3 days after the last siRNA treat-
ment (Vardhana et al., 2010). After electroporation it is important
to use low speed centrifugation to avoid damaging the cells as
specified by the Amaxa protocol.
PLANAR BILAYERS
Supported planar bilayers were formed in parallel plate flow cells
(Bioptechs). I-Ek-MCC88-103-6His2 (10–100 molecules/µm2)
and Cy5-ICAM-1-12His (200 molecules/µm2) were purified from
supernatants of S2 insect cells by immunoaffinity chromatogra-
phy (Dustin et al., 2007). Planar lipid bilayers were formed from
small unilamellar vesicles containing 12% 1,2-dioleoyl-sn-glycero-
3-[(N -(5-amino-1-carboxypentyl) iminodiacetic acid) succinyl]
(nickel salt; Avanti Polar Lipids; Dustin et al., 2007).
Ca2+ IMAGING
Control and MyH9 siRNA-treated cells were loaded with Fura-2
for 20 min at 37˚C and were incubated with bilayers for 30 min
(Vardhana et al., 2010). Images were acquired at a frame rate of
1 frame/min and at wavelength 340 nm (increases when Ca2+ is
bound) and 380 nm (decreases when Ca2+ is bound). A back-
ground corrected ratio of 340 nm/380 nm was plotted over time
as a measure of relative intracellular Ca2+ concentration.
IMAGING AND ANALYSIS
AND T cell blasts were incubated with bilayers reconstituted with
ICAM-1 and pMHC for the indicated time points and were imaged
live at 37˚C or were fixed using 2% paraformaldehyde (PFA)
and processed for immunofluorescence. TIRF imaging was car-
ried out using an Olympus IX70 microscope with a 60× NA
1.45 objective and a Hamamatsu Orca ER camera or a Nikon
Eclipse Ti with 100× NA 1.49 objective and an Andor DU897
back illuminated EMCCD camera. Solid-state lasers (Coherent)
provided illumination at 488, 561, and 641 nm and narrow pass
filters (Chroma Technology) were used for detection. Illumina-
tion for Ca2+ imaging was provided by a 150 W Xe lamp and
was performed by wide-field on an Olympus IX70 with Ludl filter
wheels. Acquisition settings were maintained constant through-
out each imaging procedure and between samples. Image analysis
was performed with Metamorph and ImageJ. Briefly, to measure
intensities, images were subtracted for background, then cells in
the subtracted images were marked with ROIs, and the intensity
FIGURE 1 | MYH9 regulates the size of the immunological synapse.
(A) AND CD4+ T cells were electroporated with a control siRNA or
Myh9#1 siRNA. The total cellular proteins were resolved by SDS-PAGE
and the levels of actin and MYH9 were determined by immunoblotting to
be reduced by 84%. (B) Bright field images of AND T cells treated with
control siRNA and Myh9#1 siRNA on bilayer presenting ICAM-1 and
I-Ek-MCC at the indicated times. Myh9#1 siRNA-treated cells display
larger lamellipodia at all times. (C) Graph representing the contact area of
cells treated with control siRNA (black) and Myh9#1 siRNA (red)
determined using IRM images at the indicated time points. Each point
shows mean and standard deviation in a single field followed over 36 min.
While the control cells display a distinct contraction, this is absent in
Myh9#1 siRNA-treated cells. (D) Scatter plot of contact area for control
(black) or Myh9#1 siRNA-treated cells for several fields at 30 min.
*p< 0.0001. This increased contact area in Myh9#1 siRNA-treated T cells
has been observed in 6 of 6 experiments.
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FIGURE 2 | MYH9 is required for cSMAC and pSMAC formation. (A)
Control and Myh9#1 siRNA-treated T cells on bilayers with ICAM-1 and
I-Ek-MCC after 3 min. Blue= ICAM-1 and Red=H57 Fab (TCR). Scale
bar=5µm. (B) ICAM-1 (top) and TCR (bottom) population average of line
scans from 14 control and 10 Myh9#1 siRNA-treated T cell synapses. (C)
ICAM-1 accumulation in the immunological synapse of cells treated with
control (green circle) or Myh9#1 (green square) siRNA at 30 min *p< 0.001.
(D) Time-dependent symmetry breaking of ICAM-1 accumulation in control
(red squares) and Myh9#1 (red) (blue diamonds) siRNA-treated T cells. This
experiment was repeated twice.
values obtained from the ROIs were plotted as raw values in scatter
plots, unless otherwise indicated. The graphs and statistical analy-
ses were performed with Microsoft Excel and Graphpad Prism, and
p-values were calculated using Student’s two-tailed unpaired t -test
or Mann–Whitney U -test if data were not normally distributed.
The experiments were performed at least twice.
RESULTS
MYH9 CONSTRAINS IMMUNOLOGICAL SYNAPSE SIZE
To assess the role of MYH9 in immunological synapse stabil-
ity and signaling we targeted the Myh9 mRNA by siRNA. Myh9
encodes the heavy chain of the type II myosin in mouse T cells
(Jacobelli et al., 2004). Electroporation of primary effector T cells
from AND TCR transgenic mice with Myh9-specific siRNA#1
(Myh9#1) resulted in a 84% reduction in MYH9 expression as
compared to control siRNA-treated T cells (Figure 1A). To eval-
uate immune synapse formation in a uniform manner for both
control and Myh9#1 siRNA-treated cells we utilized supported
planar bilayers containing ICAM-1 and I-Ek-MCC. Both of the
proteins have poly His tags and bind to the bilayers via Ni2+ chelat-
ing lipids. Bright field imaging suggested greater spreading in the
Myh9#1 siRNA-treated T cells compared to control siRNA-treated
cells (Figure 1B). To investigate SMAC formation, ICAM-1 was
labeled with Cy5 and the TCR was visualized with Alexa568-H57
Fab. We tested the control siRNA and Myh9#1 siRNA-treated T
cells in separate flow cells and allowed the cells to interact for
>30 min at 37˚C while capturing images every 90 s. In this first
set of experiments we measured the contact area by interference
reflection microscopy and tracked TCR microclusters by TIRFM.
In a representative time-course from one field, the control siRNA-
treated cells (n= 8) spread to an average maximum contact area of
100µm2 (by 3 min) and then contracted to 70µm2 (by 12 min).
TCR microclusters formed and moved centripetally to generate
a cSMAC (by 15 min; Figure 1C). In contrast, Myh9 siRNA-
treated cells (n= 3) spread to an average maximum contact area
of 130µm2 (by 6 min) and shrunk gradually over the following
30 min (Figure 1C). In a larger survey of synapse area at 30 min,
the average contact area was 62.1µm2 for control siRNA (n= 153)
and 89.7µm2 for Myh9 siRNA-treated AND T cells (n= 170),
which is significant at p< 0.0001 (Figure 1D). These results are
consistent with earlier work on the role of non-muscle myosin II
in control of stromal cell spreading (Cai et al., 2010).
MYH9 IS REQUIRED FOR SMAC FORMATION ON PLANAR BILAYERS
We next investigated the role of MYH9 in the formation of the
pSMAC and cSMAC by imaging Cy5-ICAM-1 in the bilayer and
prelabeling TCR with Alexa568-H57 Fab, respectively, in synapses
of T cells treated with a control or Myh9#1 siRNA (Figure 2A).
H57 Fab does not impair activation of T cells by the planar bilayer
(Johnson et al., 2000). In control siRNA-treated cells ICAM-1
forms a pSMAC ring and the TCR forms a cSMAC within 3 min
(Figure 2A). In contrast, Myh9#1 siRNA impaired the consoli-
dation of the pSMAC and cSMAC (Figure 2A). To quantify this
effect we performed averaging of the radial ICAM-1 and TCR
intensity for 14 control siRNA-treated and 10 Myh9#1 siRNA-
treated T cells at 3 min. This analysis demonstrated that the control
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siRNA-treated cells had a pSMAC with a bimodal ICAM-1 distri-
bution with a peak to peak diameter of 2.3µm and a cSMAC with
a unimodal H57 distribution with a width at half height of 1.5µm
(Figure 2B). Myh9#1 siRNA resulted in a significant broadening
of the bimodal ICAM-1 distribution with an increase in the peak
to peak distance to 4.4µm and a nearly flat distribution of H57
fluorescence with a width at half height of 11µm (Figure 2B).
However, the integrated intensities of the ICAM-1 and TCR signal
in the interface were 21% higher (Figure 2C) and 8% lower (not
shown), respectively, in the Myh9#1 siRNA-treated T cells com-
pared to the control siRNA-treated T cells. Increasing the time
of observation from 3 to 30 min did not change the distribution
of TCR or ICAM-1 and revealed that the Myh9 siRNA-treated
AND T cells broke their nascent immunological synapses approx-
imately eight times faster than the control siRNA-treated AND T
cells (Figure 2D, Movie S1 in Supplementary Material). Thus,
we conclude that MYH9 is required to form the pSMAC and
cSMAC based on quantitative analysis of protein distribution and
immunological synapse stability. To control for potential non-
specific effects of Myh9#1 siRNA, we tested two additional siRNAs
targeting different regions of the Myh9 transcript (Figure 3A).
When assessed for MYH9 protein silencing capability, all three
siRNA sequences alone (#1, #2, or #3) or in combination (Mix) dis-
played consistent reduction in MYH9 levels (Figure 3B, Figure A1
in Appendix). Cells treated with these siRNAs alone (#1, #2, or
#3) or in combination (Mix) exhibited comparable defects among
each other in cSMAC (Figure 3C – averaged images and line scan)
and pSMAC (Figure 3D – average images only) contraction and
an increase in cell contact area (Figure 3E), compared to cells
transfected with control siRNA. These results indicate that defects
in cSMAC and pSMAC observed upon MYH9 expression reduc-
tion of 60% or greater are likely to be due to depletion of MYH9
protein specifically, rather than an off target effect, which would
be different for each siRNA sequence. To further address whether
FIGURE 3 | SMAC defect inT cells is specific to MYH9 depletion.
(A) Sequences of three siRNA duplexes (#1, #2, #3) targeting different
regions of the Myh9 mRNA. (B) Western blot analysis for MYH9
expression in AND T cell blasts electroporated with the three individual
Myh9 siRNAs (#1, #2, #3), the mixture of all three siRNAs (Mix) or control
siRNA. MYH9 and β-actin protein levels for each condition are shown. The
value shown at the top of each lane (Rel. MYH9) represents the MYH9
band intensity normalized to actin intensity in the corresponding lane, as a
proportion of the value in the control lane. (C,D) Each image in the top row
is an average of 60 or more siRNA-treated cells (control, #1, #2, #3, Mix)
registered at the centroid for Alexa568-H57 staining of TCR (C) or
Cy5-ICAM-1 (D). The plot in (C) shows diameter profiles of TCR
(Alexa568-H57 staining) distributions with standard error of the mean
through the centroid in >60 cells for each siRNA transfection.
(E) T cell-bilayer contact area measured using interference reflection
microcopy images. Each point on the plot represents the value for a single
cell, and the bars represent mean values±SEM. The mean values of
contact areas are significantly higher in Myh9 siRNA-treated cells
(#1–110.1, #2–102.0, #3–98.4, Mix-107.0µm2) compared to control
(61.47µm2). *p-values <0.0001 vs. control.
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the involvement of MYH9 in synapse maturation is dependent on
pMHC density, and perhaps could be overcome by high pMHC
dose, we monitored cSMAC formation on bilayers reconstituted
with varying pMHC concentrations while keeping ICAM-1 den-
sity constant. We examined cSMAC intensity in the absence of
pMHC or in the presence of 10 or 100 molecules of I-Ek-MCC
perµm2. At the highest pMHC density tested (100 molecules of
I-Ek-MCC per µm2) a weak cSMAC (central TCR accumulation)
in cells treated with Myh9#1 siRNA was observed but was still
significantly attenuated compared to the control siRNA experi-
ment (Figure A2 in Appendix). This result suggests that the role
of MYH9 cannot be overcome by higher pMHC concentration.
MYH9 IS NOT REQUIRED FOR TCR MICROCLUSTER TRANSPORT
TCR signal transduction is mediated by formation of TCR micro-
clusters that are generated in the dSMAC and traverse the pSMAC.
TCR microclusters have been reported to move at 1.5–5.6µm/min
(Yokosuka et al., 2005; Varma et al., 2006). We analyzed TCR
microcluster movement after synapse formation based on imag-
ing movies of H57 Fab-tagged TCR acquired at one frame
every 2 s using maximum intensity projection over 28 s [28 s
of imaging (15 frames) were condensed into one image every
8 s; Figure 4A] as well as radial kymographs or kymographs
from individually tracked microcluster paths (Figure 4B). The
microcluster speed was determined from the slope of the line
formed by the microcluster given that the abscissa is time(s)
and the ordinate is distance (µm; Figure 4B). We made mea-
surements on 62 microclusters in control siRNA-treated T cells
and 22 microclusters in Myh9#1 siRNA-treated T cells. In con-
trast to the MYH9 dependence of anti-CD3 induced microcluster
transport reported previously (Ilani et al., 2009), transport of
pMHC induced TCR microclusters was only marginally depen-
dent on MYH9 (Figure 4C, p< 0.01). The average centripetal
velocity was 5.51± 1.32µm/min in control siRNA-treated cells
and 4.64± 2.0µm/min in Myh9#1 siRNA-treated cells. The TCR
microclusters exhibited comparable average path length (4.6µm
for control siRNA; 5.0µm for Myh9#1 siRNA) before merging into
cSMAC (control siRNA) or track termination (Myh9#1 siRNA;
Figure 4D, p= 0.57, Mann–Whitney U -test). Furthermore, the
tracks in Myh9#1 siRNA-treated cells displayed more meandering
compared to directed movement in control cells (Figure 4B), as
previously reported in the Jurkat model (Yi et al., 2012). Thus, the
failure of MHY9-depleted cells to form a cSMAC can be attrib-
uted to the failure of synapse contraction and therefore a greater
distance for the microclusters to traverse as well as the reduced
directional movement.
MYH9 INCREASES Src FAMILY KINASE ACTIVATION
Recruitment of activated SFK to TCR microclusters is one of the
earliest steps in T cell activation (Nika et al., 2010). T cell signaling
FIGURE 4 | MYH9 is not required for microcluster transport.
(A) Maximum intensity projection of TCR microclusters of Myh9#1 and
control siRNA-treated cells labeled with Alexa568-H57 Fab (TCR); 30 s of
imaging (15 frames) were condensed into one image every 8 s, to
represent the movement of TCR microclusters. (B) Radial kymograms
shows microcluster tracks over a period of 2.4 min in a control siRNA- or
Myh9#1 siRNA-treated cell (arrow shows increasing time). Note that
tracks in Myh9#1 siRNA cells are wavy and lack termination into cSMAC.
(C) Scatter plot of TCR microcluster velocities in control and Myh9#1
siRNA-treated cells. Each data point represents one microcluster, the bars
represent mean±SEM. (D) Scatter plot showing path lengths of
microclusters in control or Myh9#1 siRNA-treated cells. Each microcluster
was manually tracked from the time of appearance till time of arrest. Each
point denotes the path length value for one microcluster. The bars
represent mean±SEM. The time-lapse experiment was done thrice with
similar results.
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is sustained in the synapse by continually forming new microclus-
ters such that accumulation of active SFK at TCR microclusters will
be seen at all times during T cell activation (Campi et al., 2005;
Varma et al., 2006). We examined SFK activation loop phospho-
rylation (pSrc) in microclusters in AND T cells interacting with
bilayers containing pMHC and ICAM-1 for 15 min, staining the T
cells with an antibody against the phosphorylated SFK activation
loop, which is highly conserved between Lck and Fyn, the major
SFKs of T cells, and imaging by TIRFM to focus on the signal in
the immunological synapse. We analyzed the images by generat-
ing radial intensity profile plots (Figure 5A). The radial sweeps
originate at the centroid of the TCR signal and are stratified by
cSMAC intensity. Control siRNA-treated cells displayed efficient
cSMAC and pSMAC formation and activation loop phosphory-
lation throughout the pSMAC and dSMAC (Figure 5A). Myh9#1
siRNA-treated T cells displayed a dramatically reduced cSMAC
and disorganized peripheral accumulation of both ICAM-1 and
the phosphorylated SFK activation loop (Figure 5A). Overall, the
level of active SFK recruited to the synapse decreased by 48.7% in
Myh9#1 siRNA-treated compared to control siRNA-treated T cells
(Figure 5B, p< 0.0001).
MYH9 CONTRIBUTES TO TCR-DEPENDENT CYTOPLASMIC Ca2+
ELEVATION
We next determined if Ca2+ elevation was impaired in Myh9
siRNA-treated cells using Fura-2 ratiometric imaging in live cells
incubated on supported planar bilayers with ICAM-1 and ago-
nist pMHC at 2 molecules/µm2. Control siRNA-treated T cells
displayed a significant increase in the 340 nm/380 nm ratio indi-
cating elevated cytoplasmic Ca2+ relative to cells interacting with
ICAM-1 alone (Figure 6A, dashed line), as expected (Varma et al.,
2006). We found that Myh9#1 siRNA-treated T cells showed sig-
nificantly impaired antigen-induced Ca2+ elevation (Figure 6A).
Myh9#1 siRNA-treated cells displayed a blunted initial spike in
Ca2+ (Figure 6A) and a 27% decrease in integrated Ca2+ elevation
over 30 min, compared to control siRNA-treated cells (Figure 6B,
p< 0.0001). These results suggest that MYH9 contributes signifi-
cantly to cytoplasmic Ca2+ elevation that is an integral component
in T cell activation.
PHOSPHORYLATION OF Cas-L SUBSTRATE DOMAIN IS
MYH9-DEPENDENT
It has been suggested that the TCR might act as a mechanotrans-
ducer that is triggered in part by mechanical forces that could be
applied externally or generated by the T cell (Sims et al., 2007; Kim
et al., 2009; Li et al., 2010). To test the hypothesis that T cells gen-
erate sufficient force to activate a bona fide mechanotransduction
system we assessed the phosphoshorylation of the Cas substrate
domain of Cas-L. The Cas protein family has been shown to be
activated by mechanical unfolding and subsequence phosphory-
lation of the substrate domain (Sawada et al., 2006). Lymphocytes
express one member of the Cas family called Cas-L, which has an
established role in lymphocyte migration (Regelmann et al., 2006).
It has been recently reported that Cas-L is phosphorylated in the
immunological synapse, it was not determined if this phospho-
rylation is dependent upon TCR activation (Yu et al., 2012). As
Cas-L is not required for TCR signaling, we utilized it here as a
reporter of forces in the immunological synapse. As expected, we
detected a single band of 105 kDa in activated mouse T cells using
the phospho-Cas substrate domain antibody (Figure 7A).
Control siRNA-treated AND T cells activated on ICAM-1
and I-Ek-MCC showed a significantly higher Cas-L phosphory-
lation (924± 46 U) than on ICAM-1 only bilayers (331± 26 U)
as observed by TIRF imaging (Figures 7B,C; p< 0.0001). How-
ever, a decrease in Cas-L phosphorylation in cells treated with
Myh9 siRNA was observed both in ICAM-1 only (235± 17 U;
Figures 7B,C; p< 0.0005 vs. control siRNA) and on ICAM-1 and
I-Ek-MCC bilayers (661± 37 U; Figures 7B,C; p< 0.0001 vs. con-
trol siRNA), compared to control siRNA-treated cells. Thus, the
decreased phosphorylation of the Cas substrate domain in cells
treated with Myh9 siRNA suggests that there is significant MYH9-
dependent force generation in the immunological synapse, but
also a significant MYH9 independent component.
DISCUSSION
There has been significant recent interest in the hypothesis that
TCR triggering involves mechanotransduction, the conversion of
mechanical signals into chemical signals. This concept was first
advanced at the molecular level and later extended to incorpo-
rate cytoskeletal forces into models. The critical relationship of
antigen receptors to actomyosin cytoskeleton was first noted in
the 1970s and the role of actin polymerization in TCR signaling
was most clearly illustrated in 1995 (Braun et al., 1978; Vali-
tutti et al., 1995). In addition to the TCR, T lymphocytes also
utilize integrin family adhesion molecules to increase sensitivity
to antigenic pMHC and for effector function. Integrins are the
best-studied receptor systems for mechanotransduction involv-
ing cytoskeletal linkage. In this study we extend early evidence
that MHY9 contributes to T cell activation. We have used Myh9
siRNA as the major tool to perturb MYH9 function. We con-
firmed the specificity of this effect by assessing major phenotypes
using three independent Myh9 siRNAs. Our studies extend ear-
lier results with antigenic complexes and superantigens in cell–cell
systems (Jacobelli et al., 2004; Ilani et al., 2009) and anti-CD3
and pMHC presented by supported bilayers (Ilani et al., 2009;
Yi et al., 2012; Yu et al., 2012). We concur with earlier studies
that immune synapse formation is disrupted in the presence of
reduced levels of MYH9 (Ilani et al., 2009; Yi et al., 2012; Yu et al.,
2012), and we have uncovered a number of features that were not
previously explored. We found that treatment with Myh9 siRNA
increased the area of T cell synapses, decreased the stability of
T cell synapses, increased LFA-1–ICAM-1 interaction, decreased
accumulation of TCR microclusters at the cSMAC, decreased SFK
activation at TCR microclusters, decreased peak and integrated
cytoplasmic Ca2+ elevation, and decreased pMHC-dependent
phosphorylation of Cas-L.
We found that all three Myh9 siRNAs tested increased the
area of contact between T cells and supported planar bilayers
presenting MHC-peptide complexes. This paradoxical result is
consistent with results in stromal cells that also demonstrated
excessive spreading under several conditions in which MYH9 lev-
els were reduced or inhibited (Cai et al., 2010). This effect has been
described in terms of MYH9 providing a cytoplasmic “coherence”
that prevents fragmentation of the contact into dendritic shapes
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FIGURE 5 | MYH9 promotes recruitment of active SFK toTCR
microclusters. (A) Indirect immunofluorescence for pSrc (green),
ICAM-1 (blue), and H57 Fab (TCR, red) in AND T cells treated with
control or Myh9#1 siRNA and incubated with reconstituted bilayers
for 15 min. Below each representative cell fluorescent image is the
stack of radial line scans originating at the TCR centroid and sorted by
highest concentration TCR cSMAC, at the top, to the lowest
concentration, at the bottom. Each horizontal line represents one
pseudo-colored radial average for an individual cell. Myh9#1
siRNA-treated cells showed reduced SFK phosphorylation. (B).
Scatter plot showing the mean pSrc intensity for Myh9#1 and control
siRNA-treated cells. The integrated pSrc values for the contact areas
were significantly different *p<0.0001. The experiment was repeated
twice with similar results.
FIGURE 6 | MYH9 promotes Ca2+ mobilization in response to pMHC.
AND T cells were subjected to electroporation with control siRNA or
Myh9#1 siRNA and labeled with Fura-2 immediately before imaging to
determine the 340 nm /380 nm ratio, which is proportional to cytoplasmic
free Ca2+ concentration. (A) Traces for control siRNA-treated cells and for
Myh9#1 siRNA-treated cells. Each trace represents Fura-2 ratio for 93
(control) or 65 (Myh9#1) cells. The dashed line represents the average
Fura-2 ratio for AND T cells on bilayers with ICAM-1 alone. (B) The average
(integrated) Fura-2 ratio from 0 to 30 min with one data point for each cell.
Under these conditions of labeling and imaging the average cellular
baseline of Fura-2 on bilayers with ICAM-1 alone is 0.17 and the maximal
ratio in the presence of ionomycin and 2 mM extracellular Ca2+ is 1.2.
*Myh9#1 siRNA reduced the average Ca2+ by 27% (p<0.0001). The
experiment was repeated twice with the same result.
as protrusion and spreading continues (Cai et al., 2010). A prac-
tical aspect of this effect for T cells is that MYH9 allows lamellae
to bridge adhesion sites over gaps of several microns (Rossier
et al., 2010), which may be useful for migration in complex 3D
settings like lymph nodes. Importantly, T cells were unable to
assemble a cSMAC and pSMAC structure when subjected to any
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FIGURE 7 | Phosphorylation of Cas-L in the immunological synapse is
MYH9-dependent. (A) Western blot of non-stimulated or pMHC-ICAM-1
stimulated AND cells using an antibody against the phosphorylated Cas
substrate domain-specific antibody (Y165) that specifically recognizes a 105
kDa band corresponding to p-Cas-L. (B) Indirect p-Cas-L immunofluorescence
in control and Myh9#1 siRNA-treated cells incubated with reconstituted lipid
bilayers containing ICAM-1 alone or ICAM-1 with 10 molecules/µm2 I-Ek-MCC
for 3 min, imaged using TIRF microscopy. H57 Fab signal (TCR, in
Pseudo-colored red) and phosphorylated Cas-L signal (in Pseudo-colored
green). Both H57 and phosphorylated Cas-L signals have been contrasted to
identical levels in all of the presented images. (C) Scatter plot of average
intensity of phosphorylated Cas-L signal in TIRFM field, each point represents
the value from one cell. Addition of I-Ek-MCC to the ICAM-1 containing
bilayers increased Cas-L phosphorylation 2.8-fold (p<0.0001, Mann–Whitney
U -test) In Myh9#1 siRNA-treated cells phosphorylated Cas-L (pCas-L) is
reduced to 70% compared to control siRNA-treated cells (p<0.0001,
Mann–Whitney U -test). The red bars show the mean intensity. The
experiment was repeated three times with similar results.
of the three Myh9 siRNAs. This result is consistent with a num-
ber of recent studies that reveal defects in microcluster transport,
signaling, and pSMAC formation in cells treated with blebbis-
tatin or Myh9 siRNA. We previously found that human T cells
treated with blebbistatin or Myh9 siRNA display profound inhi-
bition of anti-CD3 triggered TCR microclusters and a decrease
in signaling triggered by superantigen mediated activation by
APCs (Ilani et al., 2009). Blebbistatin reduced TCR microclus-
ter velocity and increased meandering in Jurkat cells stimulated
with anti-CD3 (Yi et al., 2012). Another study using the same
TCR transgenic system and agonist MHC-peptide complex as our
current study also found that blebbistatin or myosin light chain
kinase inhibitors particularly inhibited the early rapid phase of
TCR microcluster transport (Yu et al., 2012). An earlier study
did not report defects in immunological synapse formation in
antigen specific T cell-APCs conjugates, but did detect defects in
T cell polarity and motility (Jacobelli et al., 2004). Conditional
knock-out of Myh9 in T cells allowed further dissection of the
motility defects and concurs with our results on increased spread-
ing (Jacobelli et al., 2009). Loss of Myh9 in human T cells has
also been associated with defects in de-adhesion from ICAM-1
(Morin et al., 2008). Our results in which Myh9 siRNA-treated T
cells become more motile on substrates with ICAM-1 and ago-
nist MHC-peptide complexes may reflect the loss of coherence
in the cytoskeleton noted by Cai et al. (2010). The observation
that LFA-1–ICAM-1 interactions increased may be due to reduced
forces acting on the interactions allowing for a longer duration
of interaction (Huppa et al., 2010). While lymphocytes do not
undergo the fragmentation of the contact area observed in stromal
cells in the absence of myosin II activity, we did observe symme-
try breaking and motility in Myh9#1 siRNA-treated T cells under
conditions where control siRNA-treated T cells displayed mostly
stable, symmetric immunological synapses. Thus, the key struc-
ture that defines the stable immunological synapse, the pSMAC,
appears to be dependent on cytoplasmic coherence generated
by MYH9.
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Our examination of signaling in microclusters focused on
recruitment of active SFKs. Ilani et al. (2009) found that anti-CD3
antibodies presented with ICAM-1 on planar bilayers generated
microclusters with normal levels of SFK activation, but decreased
ZAP-70 and LAT signaling in the presence of blebbistatin or MyH9
siRNA. More recently, studies with mouse T cells similar to those
performed here confirmed defects in ZAP-70 phosphorylation in
TCR microclusters (Yu et al., 2012). With agonist pMHC engag-
ing both TCR and CD4, we found that Myh9 siRNA reduced SFK
activation in TCR microclusters. The discrepancy with our earlier
work in Ilani et al. may reflect the role of CD4 in recruiting SFK
and may also implicate CD4 in mechanotransduction. It is impor-
tant to point out that current biochemical analysis suggests that
SFKs like Lck are constitutively active in T cells and triggering likely
depends upon concentration of the active kinases at TCR to over-
come tonic inhibition by phosphatases (Nika et al., 2010). We have
also examined exclusion of the phosphatase CD45 from micro-
clusters in the presence of blebbistatin and found that CD45 is still
excluded from microclusters (data not shown). We did not directly
investigate LAT recruitment and phosphorylation but observed
decreased Ca2+ signaling in Myh9 siRNA-treated T cells. Ca2+
elevation is downstream of LAT recruitment of phospholipase C-
γ. Similar results were obtained using the same TCR transgenic
model upon blebbistatin treatment (Yu et al., 2012). Recent stud-
ies in Jurkat T cells also found a critical role for centripetal actin
flow in PLC-γ activation (Babich et al., 2012).
There appear to be at least two actin networks in motile cells:
the lamellipodium, which is the leading structure rich in dynamic
actin, followed by the lamella, rich in tropomyosin (Ponti et al.,
2004). The lamellipodium undergoes contractile oscillations that
are myosin II dependent (Giannone et al., 2004, 2007; Dobere-
iner et al., 2006). We have proposed that in the immunological
synapse, the dSMAC is the equivalent of the lamellipodium and
the pSMAC is the equivalent of the lamella (Sims et al., 2007).
The lamellipodium is an important sensory structure and thus
the dSMAC may have a similar role in sensing the mechanics
of the T cell’s environment and APCs. T cells are sensitive to
the mechanics of their environment. Mouse T cells are sensi-
tive to substrates rigidity (Judokusumo et al., 2012). Interestingly
treatment with blebbistatin decreased mechanosensing by mouse
T cells (Judokusumo et al., 2012) supporting a critical role of
myosin II in mechanosensing during T cell activation. Human
T cells showed enhanced responses on softer substrates, suggest-
ing applications in immunotherapy (O’Connor et al., 2012). The
pSMAC environment may be particularly important for sustain-
ing signaling and amplifying Ca2+ signals. A role for ICAM-1
in costimulating Ca2+ signals has been previously noted with no
mechanism (Wulfing et al., 1998). T cells can sense single ago-
nist pMHC (Irvine et al., 2002), but require multiple pMHC for
full commitment to priming or effector function. Linking TCR
triggering to forces generated by F-actin-myosin II networks may
provide a convenient mechanism for coincidence detection in TCR
triggering to increase fidelity of T cells activation.
Cas-L is related to p130Cas, which is phosphorylated under
force-dependent unfolding of the substrate domain in cell free
and intact cell systems (Sawada et al., 2006). The antibody against
the Cas substrate domain is the same as for p130Cas and Cas-L
(Figure 6A). Supported planar bilayers are laterally fluid and it is
unlikely that the lipid linked pMHC and ICAM-1 provide much
resistance to F-actin mediated pushing forces or actomyosin-
mediated pulling. One possibility is that forces in the immuno-
logical synapse that are leading to pMHC-dependent increases in
Cas-L phosphorylation are based on internal resistance to pushing
or pulling. On the other hand, by protein prediction algorithms,
the Cas substrate domain may be unstructured (R. Bonneau,
unpublished observations) and the force needed to unfold this
domain is too small to be measured using magnetic tweezers (M. P.
S., unpublished observations), suggesting that the viscosity of the
planar bilayer membrane might be sufficiently resistant to allow
Cas-L substrate domain unfolding and phosphorylation. Knock-
out of Cas-L results in reduced T cell motility, but with no obvious
effects on T cell activation (Regelmann et al., 2006). However, Cas-
L partners with SLP-76 and Pyk2 in T cells and recent findings
show that Pyk2 is involved in CD8 T cell differentiation (Beinke
et al., 2010). These results suggest that mechanotranduction may
have roles beyond TCR triggering and motility. The phosphoryla-
tion of the Cas substrate domain leads to the recruitment of the
adapter Crk (Sawada et al., 2006). Phosphorylation of CrkL has
recently been implicated in negative regulation of natural killer
cells (Liu et al., 2012). It remains to be determined if this pathway
is relevant to positive or negative regulation of T cell activation.
Cas-L may have implications for T cell mechanotransduction as
the role of Cas-L in more biological contexts is explored.
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Movie S1 | Immunological synapse defects in Myh9#1 siRNA-treatedT
cells: pSMAC formation and immunological synapse stability. Image of
Cy5-ICAM-1 accumulated in AND TCR transgenic T cells treated with control
siRNA (Ctrl) or Myh9#1 siRNA (MyH9 KD) and interacting with supported planar
bilayers containing 20 molecules/µm2 of I-Ek-MCC and 200 molecules/µm2 of
Cy5-ICAM-1. The interval between frames is 1 min. Movie is related to Figure 2.
Ctrl cells form a well defined pSMAC and remain in place over 24 min, whereas
Myh9#1 siRNA cells fail to form a normal pSMAC and initiate migration.
Movie S2 | Immunological synapse defects in Myh9#1 siRNA-treatedT
cells: cSMAC formation. Image of Alexa568-H57 Fab labeled AND TCR
transgenic T cells treated with control siRNA (Ctrl) or Myh9#1 siRNA and
interacting with supported planar bilayers containing 20 molecules/µm2 of
I-Ek-MCC and 200 molecules/µm2 of Cy5-ICAM-1. The interval between frames
is 6 s. Movie is directly related to Figure 4. Ctrl siRNA-treated TCR microclusters
form and are transported to the cSMAC, whereas Myh9#1 siRNA-treated TCR
microclusters are transported, but tend to dissipate some distance from the
central location where the cSMAC would normally form.
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APPENDIX
FIGURE A1 | Flow cytometric analysis of ANDT cell blasts
electroporated with Myh9 siRNA. Cells electroporated with siRNA were
fixed, immunostained for MYH9 protein, and analyzed using flow
cytometry. siRNA #1, #2, #3 denotes different Myh9 siRNA sequences,
shown in Figure 3A.
FIGURE A2 |TCR accumulation as a function of concentrations of
I-Ek-MCC at 0, 10, and 100 molecules/µm2 in the substrate bilayer
with 200 molecules/µm2 ICAM-1. Left panel shows averages of 60
or more cells treated with Myh9#1 or control siRNA registered at
their centroids on bilayers of different protein concentrations. The
graph on the right shows diameter profile plots of protein
distributions with SEM across the cells from periphery to center back
out through periphery.
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